Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “VHL - Von Hippel-Lindau Syndrome”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Not applicableLooking for participantsNCT02420067
What this trial is testing

Screening for Endolymphatic Sac Tumours (ELSTs) in Von Hippel-Lindau (vHL) Patients

Who this might be right for
Von Hippel-Lindau Disease
Marie Luise Bisgaard, MD 380
Testing effectiveness (Phase 2)Ended earlyNCT01266070
What this trial is testing

TKI 258 in Von Hippel-Lindau Syndrome (VHL)

Who this might be right for
Von Hippel-Lindau Syndrome
M.D. Anderson Cancer Center 6
Not applicableLooking for participantsNCT05424016
What this trial is testing

Propranolol and Von Hippel-Lindau Disease

Who this might be right for
Hemangioblastoma of CNSVon Hippel-Lindau Disease
Assistance Publique - Hôpitaux de Paris 85
Testing effectiveness (Phase 2)Study completedNCT01436227
What this trial is testing

Pazopanib Hydrochloride in Treating Patients With Von Hippel-Lindau Syndrome

Who this might be right for
Von Hippel-Lindau Syndrome
M.D. Anderson Cancer Center 32
Very early researchEnded earlyNCT01015300
What this trial is testing

Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease

Who this might be right for
HemangioblastomasVon Hippel Lindau Disease
Dartmouth-Hitchcock Medical Center 1
Testing effectiveness (Phase 2)Study completedNCT01967537
What this trial is testing

Evaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorsVon Hippel-Lindau SyndromeHippel-Lindau Disease
National Cancer Institute (NCI) 341
Testing effectiveness (Phase 2)Study completedNCT00385333
What this trial is testing

Metabolic Mapping to Measure Retinal Metabolism

Who this might be right for
Macular DegenerationDiabetic RetinopathyHippel-Landau Disease+1 more
National Eye Institute (NEI) 28
Not applicableNot Yet RecruitingNCT07554508
What this trial is testing

Belzutifan VHL RCC HK Prospective Registry

Who this might be right for
VHL - Von Hippel-Lindau Syndrome
Chinese University of Hong Kong 100
Testing effectiveness (Phase 2)Study completedNCT00470977
What this trial is testing

Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy

Who this might be right for
Coats' DiseaseIdiopathic Retinal TelangiectasiaRetinal Angiomatous Proliferation+7 more
Manhattan Eye, Ear & Throat Hospital 18
Not applicableUnknownNCT05534854
What this trial is testing

Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer Syndromes

Who this might be right for
Renal Tumor HistologyKidney CancerRenal Cell Carcinoma+11 more
RenJi Hospital 500
Not applicableLooking for participantsNCT03749980
What this trial is testing

MyVHL: Patient Natural History Study

Who this might be right for
Von Hippel-Lindau DiseaseHereditary Leiomyomatosis and Renal Cell CancerBirt-Hogg-Dube Syndrome+1 more
Joshua Mann, MPH 10,000
Very early researchEnded earlyNCT03001349
What this trial is testing

68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors

Who this might be right for
MeningiomaMetastatic Well Differentiated Neuroendocrine NeoplasmMultiple Endocrine Neoplasia Type 1+3 more
M.D. Anderson Cancer Center 4
Large-scale testing (Phase 3)Looking for participantsNCT07405164
What this trial is testing

Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)

Who this might be right for
Von Hippel-Lindau DiseaseMalignant Neoplasms
Merck Sharp & Dohme LLC 450
Not applicableActive Not RecruitingNCT07275099
What this trial is testing

Quality of Life, Psychological Impact, and Care-related Challenges in Patients Affected by Von Hippel-Lindau Syndrome.

Who this might be right for
VHL - Von Hippel-Lindau Syndrome
IRCCS Ospedale San Raffaele 200
Testing effectiveness (Phase 2)Looking for participantsNCT04924075
What this trial is testing

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

Who this might be right for
Pheochromocytoma/ParagangliomaPancreatic Neuroendocrine TumorVon Hippel-Lindau Disease+2 more
Merck Sharp & Dohme LLC
Not applicableActive Not RecruitingNCT06195150
What this trial is testing

Overtaking Intra and Inter Tumoral Heterogeneity In Von Hippel-Lindau Related Renal Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaVHL Syndrome
IRCCS San Raffaele 3
Testing effectiveness (Phase 2)Looking for participantsNCT07167329
What this trial is testing

Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL Trial

Who this might be right for
Von Hippel LindauVon Hippel Lindau DiseaseVon Hippel Lindau-Deficient Clear Cell Renal Cell Carcinoma+5 more
José Claudio Casali da Rocha 100
Not applicableLooking for participantsNCT01496625
What this trial is testing

National Eye Institute Biorepository for Retinal Diseases

Who this might be right for
Age-Related Macular DegenerationDiabetic RetinopathyVon Hippel-Lindau Syndrome+2 more
National Eye Institute (NEI) 650
Not applicableUnknownNCT03979833
What this trial is testing

Drivers of Hypoxia-induced Angiogenesis in Tumor Development

Who this might be right for
Von Hippel-Lindau Disease
University of Copenhagen 10
Testing effectiveness (Phase 2)Ended earlyNCT00330564
What this trial is testing

Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow

Who this might be right for
Von Hippel-Lindau SyndromeRenal Cell CarcinomaHemangioblastoma
M.D. Anderson Cancer Center 15
Next Page
355